David B. Volkin

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

John W. Shiver, Tong‐Ming Fu, Ling Chen et al. · Nature · 2002 · 1.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +10

Addressing the Cold Reality of mRNA Vaccine Stability

Daan J.A. Crommelin, Thomas J. Anchordoquy, David B. Volkin et al. · Journal of Pharmaceutical Sciences · 2020 · 511 citations · Full text

Veterinary Medicine, Pharmaceutical Biotechnology, Pharmaceutics +17

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 <i>gag</i> Gene

Danilo R. Casimiro, Ling Chen, Tong‐Ming Fu et al. · Journal of Virology · 2003 · 398 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Protein Instability and Immunogenicity: Roadblocks to Clinical Application of Injectable Protein Delivery Systems for Sustained Release

Wim Jiskoot, Theodore W. Randolph, David B. Volkin et al. · Journal of Pharmaceutical Sciences · 2011 · 250 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Enzyme thermoinactivation in anhydrous organic solvents

David B. Volkin, Róbert Langer, Alexander M. Klibanov · Biotechnology and Bioengineering · 1991 · 219 citations

Life Sciences, Biochemistry, Molecular Biology +17